Federal award
CARDINAL HEALTH 414, LLC
W91YTV08P0151
Contract
Obligated and Ceiling
- Obligated (net)
- $19,634.32
- Ceiling (potential value, not spending)
- —
- Current value
- —
- Gross positive obligations
- $167,637.72
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CARDINAL HEALTH 414, LLC · CWN9UGL3NCL9
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- CARDINAL HEALTH, INC. · QJNKEYPKMBA3
- Awarding agency
- Department of War · sub-agency 2100 · office W91YTV
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W91YTV08P0151
- Award type code
- B
- Actions
- 13 · Jan 9, 2008 to Jul 25, 2012
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History13
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 25, 2012 | FY2012 | P00014 | K | −$118,659.93 | — |
| Mar 22, 2011 | FY2011 | P00013 | C | −$11,152.52 | — |
| Feb 8, 2011 | FY2011 | P00012 | C | $3,251.51 | — |
| Aug 13, 2010 | FY2010 | P00010 | C | −$3,497.11 | — |
| Feb 24, 2010 | FY2010 | P00008 | M | $0.00 | — |
| Dec 24, 2009 | FY2010 | P00007 | C | $43,660.05 | — |
| Jul 24, 2009 | FY2009 | P00006 | D | $56,323.66 | — |
| Jun 2, 2009 | FY2009 | P00005 | M | −$1,147.00 | — |
| May 15, 2009 | FY2009 | P00004 | C | −$3,546.84 | — |
| Oct 23, 2008 | FY2009 | P00003 | G | $32,728.50 | — |
| Sep 25, 2008 | FY2008 | P00002 | M | −$10,000.00 | — |
| May 21, 2008 | FY2008 | P00001 | M | $0.00 | — |
| Jan 9, 2008 | FY2008 | 0 | — | $31,674.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.
